PHI-501

Details

Stereochemistry	ACHIRAL
Molecular Formula	C29H23F3N6O2
Molecular Weight	544.5271
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1C(=O)C2=C(C=NC(NC3=CC=C(C)N=C3)=N2)C=C1C4=CC(NC(=O)C5=CC=CC(=C5)C(F)(F)F)=CC=C4C

InChI

InChIKey=MAFNESNJTDKLPG-UHFFFAOYSA-N

InChI=1S/C29H23F3N6O2/c1-16-7-9-21(35-26(39)18-5-4-6-20(11-18)29(30,31)32)13-23(16)24-12-19-14-34-28(37-25(19)27(40)38(24)3)36-22-10-8-17(2)33-15-22/h4-15H,1-3H3,(H,35,39)(H,34,36,37)

HIDE SMILES / InChI

Molecular Formula	C29H23F3N6O2
Molecular Weight	544.5271
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 12:25:41 GMT 2025` Edited by `admin` on `Wed Apr 02 12:25:41 GMT 2025`
Record UNII	73ET74LVY6
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PHI-501

Code

English

PHI501

Preferred Name

English

BENZAMIDE, N-(3-(7,8-DIHYDRO-7-METHYL-2-((6-METHYL-3-PYRIDINYL)AMINO)-8-OXOPYRIDO(3,4-D)PYRIMIDIN-6-YL)-4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-

Systematic Name

English

N-(4-METHYL-3-(7-METHYL-2-((6-METHYLPYRIDIN-3-YL)AMINO)-8-OXO-7,8-DIHYDROPYRIDO(3,4-D)PYRIMIDIN-6-YL)PHENYL)-3-(TRIFLUOROMETHYL)BENZAMIDE

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

847921

Created by admin on Wed Apr 02 12:25:41 GMT 2025 , Edited by admin on Wed Apr 02 12:25:41 GMT 2025

Code System Code Type Description

FDA UNII

73ET74LVY6

Created by admin on Wed Apr 02 12:25:41 GMT 2025 , Edited by admin on Wed Apr 02 12:25:41 GMT 2025

PRIMARY

PUBCHEM

159507876

Created by admin on Wed Apr 02 12:25:41 GMT 2025 , Edited by admin on Wed Apr 02 12:25:41 GMT 2025

PRIMARY

CAS

2470433-36-2

Created by admin on Wed Apr 02 12:25:41 GMT 2025 , Edited by admin on Wed Apr 02 12:25:41 GMT 2025

PRIMARY

Related Record Type Details


					FMN4HCP4P3

GTPASE NRAS

TARGET -> INHIBITOR

Amount: